SI2248807T1 - N-fenil-2-pirimidin-aminski derivati - Google Patents
N-fenil-2-pirimidin-aminski derivatiInfo
- Publication number
- SI2248807T1 SI2248807T1 SI200332291T SI200332291T SI2248807T1 SI 2248807 T1 SI2248807 T1 SI 2248807T1 SI 200332291 T SI200332291 T SI 200332291T SI 200332291 T SI200332291 T SI 200332291T SI 2248807 T1 SI2248807 T1 SI 2248807T1
- Authority
- SI
- Slovenia
- Prior art keywords
- pyrimidine
- phenyl
- amine derivatives
- amine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0202873.6A GB0202873D0 (en) | 2002-02-07 | 2002-02-07 | Organic compounds |
EP10171388.1A EP2248807B1 (en) | 2002-02-07 | 2003-02-06 | N-phenyl-2-pyrimidine-amine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2248807T1 true SI2248807T1 (sl) | 2013-10-30 |
Family
ID=9930607
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200332291T SI2248807T1 (sl) | 2002-02-07 | 2003-02-06 | N-fenil-2-pirimidin-aminski derivati |
SI200332155T SI1474408T1 (sl) | 2002-02-07 | 2003-02-06 | N fenil pirimidin aminski derivati |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200332155T SI1474408T1 (sl) | 2002-02-07 | 2003-02-06 | N fenil pirimidin aminski derivati |
Country Status (26)
Country | Link |
---|---|
US (8) | US7456283B2 (sl) |
EP (2) | EP2248807B1 (sl) |
JP (2) | JP4653954B2 (sl) |
KR (1) | KR101027044B1 (sl) |
CN (2) | CN100347162C (sl) |
AU (1) | AU2003244444B2 (sl) |
BR (2) | BR0307529A (sl) |
CA (2) | CA2474738C (sl) |
CO (1) | CO5601018A2 (sl) |
CY (2) | CY1112938T1 (sl) |
DK (2) | DK2248807T3 (sl) |
EC (2) | ECSP045220A (sl) |
ES (2) | ES2425980T3 (sl) |
GB (1) | GB0202873D0 (sl) |
HK (2) | HK1145322A1 (sl) |
IL (3) | IL163158A (sl) |
MX (1) | MXPA04007642A (sl) |
NO (2) | NO327366B1 (sl) |
NZ (3) | NZ534315A (sl) |
PL (1) | PL209475B1 (sl) |
PT (2) | PT1474408E (sl) |
RU (2) | RU2370493C2 (sl) |
SG (1) | SG160195A1 (sl) |
SI (2) | SI2248807T1 (sl) |
WO (1) | WO2003066613A1 (sl) |
ZA (1) | ZA200405970B (sl) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0202873D0 (en) | 2002-02-07 | 2002-03-27 | Novartis Ag | Organic compounds |
AU2003242988A1 (en) * | 2003-06-06 | 2005-01-04 | Adibhatla Kali Sathya Bhujanga Rao | Process for the preparation of the anti-cancer drug imatinib and its analogues |
ES2338557T3 (es) * | 2003-06-13 | 2010-05-10 | Novartis Ag | Derivados de la 2-aminopirimidina utilizados como inhibidores de la raf cinasa. |
MY144177A (en) | 2004-02-04 | 2011-08-15 | Novartis Ag | Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide. |
US7507821B2 (en) | 2004-12-30 | 2009-03-24 | Chemagis Ltd. | Process for preparing Imatinib |
US8067421B2 (en) | 2006-04-27 | 2011-11-29 | Sicor Inc. | Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α |
US7977348B2 (en) | 2006-04-27 | 2011-07-12 | Sicor Inc. | Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α |
US20060223816A1 (en) * | 2006-05-08 | 2006-10-05 | Chemagis Ltd. | Imatinib mesylate alpha form and production process therefor |
EP2068835A2 (en) * | 2006-09-01 | 2009-06-17 | Teva Pharmaceutical Industries Ltd. | Imatinib compositions |
PT2068938E (pt) | 2006-09-22 | 2011-03-23 | Novartis Ag | Optimização do tratamento da leucemia filadélfia positiva com o inibidor de tirosina quinase abl imatinib |
EP1988089A1 (en) | 2006-10-26 | 2008-11-05 | Sicor, Inc. | Imatinib base, and imatinib mesylate and processes for preparation thereof |
WO2008057291A2 (en) * | 2006-10-26 | 2008-05-15 | Sicor Inc. | Crystalline and amorphous imatinib base, imatinib mesylate- and processes for preparation thereof |
EP2074095B1 (en) * | 2006-11-16 | 2014-07-02 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Process for the preparation of imatinib and intermediates thereof |
CN100451015C (zh) * | 2007-02-14 | 2009-01-14 | 杭州盛美医药科技开发有限公司 | 一种伊马替尼的制备方法 |
US7550591B2 (en) * | 2007-05-02 | 2009-06-23 | Chemagis Ltd. | Imatinib production process |
EP2152079A4 (en) | 2007-06-04 | 2011-03-09 | Avila Therapeutics Inc | HETEROCYCLIC COMPOUNDS AND USES THEREOF |
WO2009042803A1 (en) * | 2007-09-25 | 2009-04-02 | Teva Pharmaceutical Industries Ltd. | Imatinib compositions |
WO2009080366A1 (en) * | 2007-12-22 | 2009-07-02 | Synthon B.V. | A process of making imatinib |
CN101497601B (zh) * | 2008-01-29 | 2012-11-07 | 福建南方制药股份有限公司 | 伊马替尼的合成方法 |
PL215042B1 (pl) * | 2008-08-01 | 2013-10-31 | Temapharm Spolka Z Ograniczona Odpowiedzialnoscia | Sposób wytwarzania imatinibu |
KR20100021321A (ko) * | 2008-08-14 | 2010-02-24 | 일양약품주식회사 | Ν-페닐-2-피리미딘-아민 유도체의 제조방법 |
EP2370078A1 (en) | 2008-12-01 | 2011-10-05 | Novartis AG | Method of optimizing the treatment of philadelphia-positive leukemia with imatinib mesylate |
US20100330130A1 (en) | 2009-05-22 | 2010-12-30 | Actavis Group Ptc Ehf | Substantially pure imatinib or a pharmaceutically acceptable salt thereof |
CN101654416B (zh) * | 2009-09-16 | 2013-06-05 | 成都神黄医药科技开发有限公司 | N-[3-硝基-4-甲基-苯基]-4-醛基-苯甲酰胺及其制备方法以及其衍生物的制备方法 |
WO2011070588A1 (en) | 2009-12-10 | 2011-06-16 | Arch Pharmalabs Limited | Process for the preparation of imatinib and salts thereof |
WO2011095835A1 (en) | 2010-02-02 | 2011-08-11 | Actavis Group Ptc Ehf | Highly pure imatinib or a pharmaceutically acceptable salt thereof |
US8609842B2 (en) | 2010-04-23 | 2013-12-17 | Fujian South Pharmaceutical Co., Ltd. | Method for synthesizing Imatinib |
SI2582689T1 (sl) | 2010-06-18 | 2017-05-31 | Krka, D.D., Novo Mesto | Nova polimorfna oblika imatinib baze in priprava njenih soli |
TR201007005A2 (tr) | 2010-08-23 | 2011-09-21 | Mustafa Nevzat İlaç Sanayi̇i̇ A.Ş. | İmatinib baz üretim yöntemi |
WO2013035102A1 (en) | 2011-09-05 | 2013-03-14 | Natco Pharma Limited | Processes for the preparation of imatinib base and intermediates thereof |
US20140288073A1 (en) | 2011-10-28 | 2014-09-25 | Novartis Ag | Method of Treating Gastrointestinal Stromal Tumors |
WO2013063003A1 (en) | 2011-10-28 | 2013-05-02 | Novartis Ag | Method of treating gastrointestinal stromal tumors |
GB2514285B (en) | 2012-02-13 | 2018-07-18 | Grindeks Jsc | Intermediates for a novel process of preparing imatinib and related tyrosine kinase inhibitors |
BR112015000349A2 (pt) | 2012-07-11 | 2017-06-27 | Novartis Ag | método de tratamento de tumores estromais gastrointestinais |
CN102827144A (zh) * | 2012-09-05 | 2012-12-19 | 湖南欧亚生物有限公司 | 一种伊马替尼的制备方法 |
RU2537398C1 (ru) * | 2013-08-20 | 2015-01-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Сибирский государственный технологический университет" (СибГТУ) | Гексазамещенные пара-аминофенолы с ариламидными группами в 2,6-положениях по отношению к гидроксилу |
CN103588754B (zh) * | 2013-11-04 | 2015-05-27 | 遵义医学院 | 伊马替尼的制备方法 |
TWI674094B (zh) | 2016-10-17 | 2019-10-11 | 日商德爾塔菲製藥股份有限公司 | 治療或緩解慢性骨髓性白血病用之醫藥組合物 |
PL3539138T3 (pl) | 2016-11-11 | 2021-12-13 | Curium Us Llc | Sposoby generowania germanu-68 ze zmniejszoną ilością części lotnych |
EP3333162A1 (en) | 2016-12-12 | 2018-06-13 | Silesian Catalysts sp. z o.o. | Metod for preparing n-(2-methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine |
RU2764243C2 (ru) | 2017-09-22 | 2022-01-14 | ДЖУБИЛАНТ ЭПИПЭД ЭлЭлСи | Гетероциклические соединения в качестве ингибиторов PAD |
HUE061607T2 (hu) | 2017-10-18 | 2023-07-28 | Jubilant Epipad LLC | Imidazopiridin vegyületek mint PAD inhibitorok |
CA3080677A1 (en) | 2017-11-06 | 2019-05-09 | Jubilant Prodel LLC | Pyrimidine derivatives as inhibitors of pd1/pd-l1 activation |
EP3704120B1 (en) | 2017-11-24 | 2024-03-06 | Jubilant Episcribe LLC | Heterocyclic compounds as prmt5 inhibitors |
CN108164505B (zh) * | 2018-01-16 | 2020-11-03 | 扬州大学 | 一种伊马替尼的合成方法 |
CN111683976B (zh) | 2018-02-05 | 2022-11-18 | 生物辐射实验室股份有限公司 | 具有阴离子交换-疏水混合模式配体的色谱树脂 |
AU2019234185A1 (en) | 2018-03-13 | 2020-10-01 | Jubilant Prodel LLC. | Bicyclic compounds as inhibitors of PD1/PD-L1 interaction/activation |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE531480C (de) * | 1929-07-03 | 1931-08-10 | I G Farbenindustrie Akt Ges | Verfahren zur Darstellung von Aryliden einer unsymmetrischen o-Xylenolcarbonsaeure |
US2808433A (en) * | 1953-08-21 | 1957-10-01 | Du Pont | Benzene dicarboxylic acid derivatives |
GB862127A (en) | 1958-07-04 | 1961-03-01 | Ici Ltd | Derivatives of 2-hydroxy-3-naphthanilide |
US3505433A (en) * | 1965-03-08 | 1970-04-07 | Hooker Chemical Corp | 2-haloperfluoro-1-cycloalken-1-ylphosphoryl compounds |
US3505389A (en) * | 1966-08-18 | 1970-04-07 | Hooker Chemical Corp | 4-amino-2,3,5,6-tetrachlorobenzoic acid and derivatives thereof |
US3505398A (en) | 1966-09-22 | 1970-04-07 | Standard Oil Co | Terephthalic acid crystallization |
US3763234A (en) | 1970-12-03 | 1973-10-02 | Halcon International Inc | Preparation of amides |
JPS4987761U (sl) | 1972-11-17 | 1974-07-30 | ||
JPS563375B2 (sl) * | 1972-12-25 | 1981-01-24 | ||
JPS5720923B2 (sl) * | 1974-04-02 | 1982-05-04 | ||
US4281000A (en) * | 1979-07-09 | 1981-07-28 | American Cyanamid Company | Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents |
JPS5665804A (en) * | 1979-11-01 | 1981-06-03 | Ishihara Sangyo Kaisha Ltd | Control agent against injurious organism |
DE3305755A1 (de) | 1983-02-19 | 1984-08-23 | Gödecke AG, 1000 Berlin | N-phenyl-benzamid-derivate, verfahren zu deren herstellung und deren verwendung bei der bekaempfung von erkranungen des immunsystems |
US4623486A (en) * | 1985-05-29 | 1986-11-18 | Pfizer Inc. | [4-substituted benzoyloxy]-N-substituted-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides having anti-arthritic activity |
NZ219974A (en) | 1986-04-22 | 1989-08-29 | Goedecke Ag | N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases |
JP2894804B2 (ja) * | 1989-07-19 | 1999-05-24 | 武田薬品工業株式会社 | 2―アミノ―5―メチルベンゾフェノン類及びその製造法 |
JPH03130252U (sl) | 1990-04-11 | 1991-12-27 | ||
FR2664895B1 (fr) * | 1990-07-20 | 1992-10-30 | Theramex Laboratoire | Nouveaux derives de la 6-methyl 19-nor progesterone, substitues en 3 et leur procede d'obtention. |
DE4110483A1 (de) | 1991-03-30 | 1992-10-01 | Bayer Ag | Substituierte salicylamide, mittel gegen pflanzenkrankheiten |
TW225528B (sl) * | 1992-04-03 | 1994-06-21 | Ciba Geigy Ag | |
US5521184A (en) | 1992-04-03 | 1996-05-28 | Ciba-Geigy Corporation | Pyrimidine derivatives and processes for the preparation thereof |
FR2689925B1 (fr) | 1992-04-08 | 1994-05-27 | Valeo Securite Habitacle | Dispositif de verrouillage d'une serrure dans son support. |
US5543520A (en) * | 1993-10-01 | 1996-08-06 | Ciba-Geigy Corporation | Pyrimidine derivatives |
DE4428380A1 (de) * | 1994-08-11 | 1996-02-15 | Bayer Ag | 4-Trifluormethylbenzamide |
JPH0987761A (ja) | 1995-09-22 | 1997-03-31 | Nikko Kinzoku Kk | 銅転炉スラグからの銅の回収方法 |
JP3130252B2 (ja) | 1996-07-12 | 2001-01-31 | 小糸工業株式会社 | 座席のヘッドレスト装置 |
JP2002511090A (ja) * | 1997-06-30 | 2002-04-09 | アール・ジェイ・レイノルズ・タバコ・カンパニー | Cns疾患の予防と治療用3−ピリジル−1−アザ−ビシクロ−アルカン誘導体 |
CO4940418A1 (es) * | 1997-07-18 | 2000-07-24 | Novartis Ag | Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso |
TR200003353T2 (tr) * | 1998-05-15 | 2001-04-20 | Astrazeneca Ab | Sitokinlerin aracılık ettiği hastalıkların tedavisi için benzamit türevleri |
TR200100840T2 (tr) | 1998-09-25 | 2001-10-22 | Astrazeneca Ab | Benzamid türevleri ve bunların sitokin inhibe edicileri olarak kullanımı |
GB9824579D0 (en) * | 1998-11-10 | 1999-01-06 | Novartis Ag | Organic compounds |
GB9924092D0 (en) * | 1999-10-13 | 1999-12-15 | Zeneca Ltd | Pyrimidine derivatives |
GB0202873D0 (en) | 2002-02-07 | 2002-03-27 | Novartis Ag | Organic compounds |
GB2398565A (en) * | 2003-02-18 | 2004-08-25 | Cipla Ltd | Imatinib preparation and salts |
US7338957B2 (en) * | 2003-08-28 | 2008-03-04 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
-
2002
- 2002-02-07 GB GBGB0202873.6A patent/GB0202873D0/en not_active Ceased
-
2003
- 2003-02-06 CN CNB038035561A patent/CN100347162C/zh not_active Expired - Fee Related
- 2003-02-06 EP EP10171388.1A patent/EP2248807B1/en not_active Expired - Lifetime
- 2003-02-06 DK DK10171388.1T patent/DK2248807T3/da active
- 2003-02-06 SG SG200605266-6A patent/SG160195A1/en unknown
- 2003-02-06 CA CA2474738A patent/CA2474738C/en not_active Expired - Fee Related
- 2003-02-06 DK DK03737319.8T patent/DK1474408T3/da active
- 2003-02-06 ES ES10171388T patent/ES2425980T3/es not_active Expired - Lifetime
- 2003-02-06 WO PCT/EP2003/001188 patent/WO2003066613A1/en active Application Filing
- 2003-02-06 KR KR1020047011670A patent/KR101027044B1/ko active IP Right Grant
- 2003-02-06 BR BR0307529-0A patent/BR0307529A/pt not_active IP Right Cessation
- 2003-02-06 CA CA2737565A patent/CA2737565C/en not_active Expired - Fee Related
- 2003-02-06 JP JP2003565987A patent/JP4653954B2/ja not_active Expired - Fee Related
- 2003-02-06 ES ES03737319T patent/ES2384872T3/es not_active Expired - Lifetime
- 2003-02-06 NZ NZ534315A patent/NZ534315A/en not_active IP Right Cessation
- 2003-02-06 PL PL371197A patent/PL209475B1/pl unknown
- 2003-02-06 BR BRPI0307529-0A patent/BRPI0307529B1/pt unknown
- 2003-02-06 EP EP03737319A patent/EP1474408B1/en not_active Expired - Lifetime
- 2003-02-06 RU RU2004126941/04A patent/RU2370493C2/ru not_active IP Right Cessation
- 2003-02-06 US US10/503,538 patent/US7456283B2/en not_active Expired - Fee Related
- 2003-02-06 SI SI200332291T patent/SI2248807T1/sl unknown
- 2003-02-06 NZ NZ554430A patent/NZ554430A/en not_active IP Right Cessation
- 2003-02-06 AU AU2003244444A patent/AU2003244444B2/en not_active Ceased
- 2003-02-06 PT PT03737319T patent/PT1474408E/pt unknown
- 2003-02-06 SI SI200332155T patent/SI1474408T1/sl unknown
- 2003-02-06 CN CNA2007100860099A patent/CN101016262A/zh active Pending
- 2003-02-06 MX MXPA04007642A patent/MXPA04007642A/es active IP Right Grant
- 2003-02-06 PT PT101713881T patent/PT2248807E/pt unknown
- 2003-02-06 NZ NZ569731A patent/NZ569731A/en not_active IP Right Cessation
-
2004
- 2004-07-22 IL IL163158A patent/IL163158A/en not_active IP Right Cessation
- 2004-07-27 ZA ZA200405970A patent/ZA200405970B/en unknown
- 2004-08-04 EC EC2004005220A patent/ECSP045220A/es unknown
- 2004-08-05 CO CO04076194A patent/CO5601018A2/es active IP Right Grant
- 2004-09-03 NO NO20043685A patent/NO327366B1/no not_active IP Right Cessation
-
2005
- 2005-04-28 HK HK10111709.7A patent/HK1145322A1/xx not_active IP Right Cessation
- 2005-04-28 HK HK05103664.4A patent/HK1070893A1/xx not_active IP Right Cessation
-
2007
- 2007-08-28 US US11/845,924 patent/US7579467B2/en not_active Expired - Fee Related
- 2007-08-28 US US11/845,914 patent/US7825247B2/en not_active Expired - Fee Related
- 2007-08-28 US US11/845,946 patent/US20070293683A1/en not_active Abandoned
- 2007-08-28 US US11/845,934 patent/US7816359B2/en not_active Expired - Fee Related
- 2007-12-26 RU RU2007148217/04A patent/RU2007148217A/ru unknown
-
2008
- 2008-02-21 IL IL189657A patent/IL189657A/en not_active IP Right Cessation
- 2008-02-21 IL IL189658A patent/IL189658A/en not_active IP Right Cessation
-
2009
- 2009-02-02 US US12/363,838 patent/US20090137805A1/en not_active Abandoned
- 2009-05-20 NO NO20091976A patent/NO20091976L/no not_active Application Discontinuation
- 2009-07-28 EC EC2009005220A patent/ECSP095220A/es unknown
-
2010
- 2010-03-09 JP JP2010051939A patent/JP2010138194A/ja active Pending
-
2012
- 2012-05-17 US US13/473,732 patent/US20120226039A1/en not_active Abandoned
- 2012-06-29 CY CY20121100584T patent/CY1112938T1/el unknown
-
2013
- 2013-08-09 CY CY20131100686T patent/CY1114351T1/el unknown
-
2014
- 2014-09-30 US US14/502,112 patent/US9573928B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL189658A0 (en) | N-phenyl-2-pyrimidine-amine derivatives | |
AP1850A (en) | Spiroindolineplperidine derivatives | |
EG24050A (en) | Heterocylocarboxamide derivatives | |
HK1077068A1 (en) | Azolidinone-vinyl fused-benzene derivatives | |
IL166121A0 (en) | Indole-3-sulphur derivatives | |
EP1522540A4 (en) | AZAARENE DERIVATIVES | |
PL376475A1 (en) | N-substituted-2-oxodihydropyridine derivatives | |
ZA200500471B (en) | N-biarylmethyl aminocycloalkanecarboxamide derivatives | |
HK1088602A1 (en) | 2-pyridinecarboxamide derivatives | |
HK1088326A1 (en) | Piperidine-benzenesulfonamide derivatives | |
HK1089443A1 (en) | Imidazol-4-yl-ethynyl-pyridine derivatives | |
GB0317665D0 (en) | Qinazoline derivatives | |
PT1682493E (pt) | Derivados de aminoacetonitrilo | |
IL175189A0 (en) | N-thiazol-2-yl-benzamide derivatives | |
AU2003213185A8 (en) | Arylsulfone derivatives | |
PL1706373T3 (pl) | Pochodne amidoacetonitrylu | |
AU2003222659A8 (en) | 23-o-substituted 5-o-mycaminosyltylonide derivatives | |
EP1531854A4 (en) | O-DERIVATED NOCATHIACIN DERIVATIVES | |
GB0319793D0 (en) | Pyridinylmorpholine derivatives | |
GB0213488D0 (en) | 2-Naphthamide derivatives | |
AU2003243397A8 (en) | Homo-camptothecin derivatives | |
AU2003285777A8 (en) | 3-substituted-4-pyrimidone derivatives | |
GB0219894D0 (en) | Dihydropyridinone derivatives | |
GB0210512D0 (en) | Tetrahydro-napthalene derivatives | |
AU2003280822A8 (en) | Beauveriolide derivatives |